First Injection of Dotarem® (gadoterate meglumine) in US

26.07.2013 09:31

Guerbet LLC, USA (July 24, 2013)

Princeton, NJ -- Guerbet announced today that Cincinnati Children's Hospital Medical Center (Cincinnati Children’s) last week performed the first US injection of Dotarem® (gadoterate meglumine), the only macrocyclic and ionic gadolinium-based contrast agent (GBCA) approved by the US Food and Drug Administration. The procedure was performed in a school age child. 

Read the press release